159 related articles for article (PubMed ID: 38213034)
1. Frequency of Fabry disease in chronic kidney disease patients including patients on renal replacement therapy in Korea.
Cho E; Park JT; Yoo TH; Kim SW; Park CW; Han SS; Kim YH; Kwon YJ
Kidney Res Clin Pract; 2024 Jan; 43(1):71-81. PubMed ID: 38213034
[TBL] [Abstract][Full Text] [Related]
2. The Ckd. Qld fabRy Epidemiology (aCQuiRE) study protocol: identifying the prevalence of Fabry disease amongst patients with kidney disease in Queensland, Australia.
Mallett A; Kearey P; Cameron A; Healy H; Denaro C; Thomas M; Lee VW; Stark S; Fuller M; Hoy WE
BMC Nephrol; 2020 Feb; 21(1):58. PubMed ID: 32087678
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of Fabry disease among 1009 unrelated patients with hypertrophic cardiomyopathy: a Russian nationwide screening program using NGS technology.
Savostyanov K; Pushkov A; Zhanin I; Mazanova N; Trufanov S; Pakhomov A; Alexeeva A; Sladkov D; Asanov A; Fisenko A
Orphanet J Rare Dis; 2022 May; 17(1):199. PubMed ID: 35578305
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Fabry disease in dialysis patients: Western Australia Fabry disease screening study - the FoRWARD study.
Jahan S; Sarathchandran S; Akhter S; Goldblatt J; Stark S; Crawford D; Mallett A; Thomas M
Orphanet J Rare Dis; 2020 Jan; 15(1):10. PubMed ID: 31931840
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive testing algorithm for the diagnosis of Fabry disease in males and females.
Stiles AR; Zhang H; Dai J; McCaw P; Beasley J; Rehder C; Koeberl DD; McDonald M; Bali DS; Young SP
Mol Genet Metab; 2020 Jul; 130(3):209-214. PubMed ID: 32418857
[TBL] [Abstract][Full Text] [Related]
6. Serum globotriaosylceramide assay as a screening test for fabry disease in patients with ESRD on maintenance dialysis in Korea.
Kim JY; Hyun YY; Lee JE; Yoon HR; Kim GH; Yoo HW; Cho ST; Chun NW; Jeoung BC; Kim HJ; Kim KW; Kim SN; Kim YA; Lee HA; Lee JY; Lee YC; Lim HK; Oh KS; Son SH; Yu BH; Wee KS; Lee EJ; Lee YK; Noh JW; Kim SJ; Choi KB; Yu SH; Pyo HJ; Kwon YJ
Korean J Intern Med; 2010 Dec; 25(4):415-21. PubMed ID: 21179280
[TBL] [Abstract][Full Text] [Related]
7. Systematic gene therapy derived from an investigative study of AAV2/8 vector gene therapy for Fabry disease.
Deng M; Zhou H; He S; Qiu H; Wang Y; Zhao AY; Mu Y; Li F; Zhao AZ
Orphanet J Rare Dis; 2023 Sep; 18(1):275. PubMed ID: 37670350
[TBL] [Abstract][Full Text] [Related]
8. Agalsidase-β should be proposed as first line therapy in classic male Fabry patients with undetectable α-galactosidase A activity.
Nowak A; Dormond O; Monzambani V; Huynh-Do U; Barbey F
Mol Genet Metab; 2022; 137(1-2):173-178. PubMed ID: 36087505
[TBL] [Abstract][Full Text] [Related]
9. Plasma Globotriaosylsphingosine Level as a Primary Screening Target for Fabry Disease in Patients With Left Ventricular Hypertrophy.
Yamashita S; Saotome M; Satoh H; Kajihara J; Mochizuki Y; Mizuno K; Nobuhara M; Miyajima K; Kumazawa A; Tominaga H; Takase H; Tawarahara K; Wakahara N; Matsunaga M; Wakabayashi Y; Matsumoto Y; Terada H; Sano M; Ohtani H; Urushida T; Hayashi H; Ishii S; Maruyama H; Maekawa Y
Circ J; 2019 Aug; 83(9):1901-1907. PubMed ID: 31308318
[TBL] [Abstract][Full Text] [Related]
10. [Screening Test of Fabry Disease in Patients with Renal Replacement Therapy in the City of Modena].
Alfano G; Ganda N; Cerami C; Mori G; Fontana F; Cappelli G
G Ital Nefrol; 2018 Mar; 35(2):. PubMed ID: 29582965
[TBL] [Abstract][Full Text] [Related]
11. Results of Fabry Disease Screening in Male Pre-End Stage Renal Disease Patients with Unknown Etiology Found Through the Platform of a Chronic Kidney Disease Education Program in a Northern Taiwan Medical Center.
Lin CJ; Chien YH; Lai TS; Shih HM; Chen YC; Pan CF; Chen HH; Hwu WL; Wu CJ
Kidney Blood Press Res; 2018; 43(5):1636-1645. PubMed ID: 30380558
[TBL] [Abstract][Full Text] [Related]
12. Screening of Fabry disease in patients with chronic kidney disease in Japan.
Nagata A; Nasu M; Kaida Y; Nakayama Y; Kurokawa Y; Nakamura N; Shibata R; Hazama T; Tsukimura T; Togawa T; Saito S; Sakuraba H; Fukami K
Nephrol Dial Transplant; 2021 Dec; 37(1):115-125. PubMed ID: 34282462
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of Fabry disease in patients in hemodialysis in the Madrid community.
Corchete Prats E; González-Parra E; Vega A; Macías N; Delgado M; Fernández M; Sánchez RJ; Álvarez L; Miranda RJ; Vian J; López V; Mérida E; Pereira M; Sapiencia D; Andrés N; Muñoz P; Gil Y; Sánchez M; Cases C; Gil B; García A; Sainz V; Alexandru S; Pampa S; López M; Flor JC; Estrada PN; Berlanga JR; Zamora R; Sánchez R; Rodríguez-Osorio L; Fraile C; Caravaca-Fontán F; Moratilla C; Cabré C; Furaz K; Nieto L; Villaverde MT; Tapia CG; Cedeño S; Castellano S; Valdés E; Ferreira M; Martínez P; Sanz M; Sánchez M; Ríos F; Palomo S; Serrano ML; Blanco A; Espinel L; Tornero F; Herrero JA
Nefrologia (Engl Ed); 2023; 43(4):435-441. PubMed ID: 36564230
[TBL] [Abstract][Full Text] [Related]
14. Screening of Fabry Disease of patients in renal replacement therapy in a population from Lazio (Italy).
Marrone G; Angelico R; Di Lauro M; Sargentini E; Manzia TM; Tisone G; Mitterhofer AP; Della Morte Canosci D; Tesauro M; Di Daniele N; Noce A
Eur Rev Med Pharmacol Sci; 2023 Apr; 27(7):3134-3141. PubMed ID: 37070916
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Fabry disease in male dialysis patients: Argentinean screening study.
Frabasil J; Durand C; Sokn S; Gaggioli D; Carozza P; Carabajal R; Politei J; Schenone AB
JIMD Rep; 2019 Jul; 48(1):45-52. PubMed ID: 31392112
[TBL] [Abstract][Full Text] [Related]
16. Screening for Fabry disease in patients undergoing dialysis for chronic renal failure in Turkey: identification of new case with novel mutation.
Okur I; Ezgu F; Biberoglu G; Tumer L; Erten Y; Isitman M; Eminoglu FT; Hasanoglu A
Gene; 2013 Sep; 527(1):42-7. PubMed ID: 23756194
[TBL] [Abstract][Full Text] [Related]
17. Accuracy diagnosis improvement of Fabry disease from dried blood spots: Enzyme activity, lyso-Gb3 accumulation and GLA gene sequencing.
Delarosa-Rodríguez R; Santotoribio JD; Paula HA; González-Meneses A; García-Morillo S; Jiménez-Arriscado P; Guerrero JM; Macher HC
Clin Genet; 2021 Jun; 99(6):761-771. PubMed ID: 33527381
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and Management of Fabry Disease in High-Risk Renal Disease Patients in Taiwan: A Single Center Study.
Shih CY; You ZH; Tsai SF; Wu MJ; Yu TM; Chuang YW; Chen CH
Transplant Proc; 2023 May; 55(4):788-791. PubMed ID: 37230899
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of lyso-globotriaosylsphingosine in dried blood spots in the differential diagnosis between multiple sclerosis and Anderson-Fabry's disease.
Olivera S; Iñiguez C; García-Fernández L; Sierra JL; Camón AM; Menao S; Torralba MÁ
Mult Scler Relat Disord; 2020 Feb; 38():101466. PubMed ID: 31715500
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis.
Maruyama H; Miyata K; Mikame M; Taguchi A; Guili C; Shimura M; Murayama K; Inoue T; Yamamoto S; Sugimura K; Tamita K; Kawasaki T; Kajihara J; Onishi A; Sugiyama H; Sakai T; Murata I; Oda T; Toyoda S; Hanawa K; Fujimura T; Ura S; Matsumura M; Takano H; Yamashita S; Matsukura G; Tazawa R; Shiga T; Ebato M; Satoh H; Ishii S
Genet Med; 2019 Jan; 21(1):44-52. PubMed ID: 29543226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
